Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Table 1.

Baseline characteristics of the study population (N = 556).

More »

Table 1 Expand

Table 2.

Associations between urinary free light chain/creatinine ratios and albumin/creatinine ratio with other baseline variables.

More »

Table 2 Expand

Fig 1.

Scatter plots of urinary kappa/creatinine ratio (a) and lambda/creatinine ratio (b) by estimated glomerular filtration rate.

Scales are logarithmic. Abbreviations: GFR = glomerular filtration rate.

More »

Fig 1 Expand

Fig 2.

Scatter plots of urinary kappa/creatinine ratio (a) and lambda/creatinine ratio (b) by urinary albumin/creatinine ratio.

Scales are logarithmic.

More »

Fig 2 Expand

Fig 3.

Scatter plots of urinary kappa/creatinine ratio by serum kappa (a) and urinary lambda/creatinine ratio by serum lambda (b).

Scales are logarithmic.

More »

Fig 3 Expand

Fig 4.

Restricted cubic splines of the subhazard ratio (solid line, with 95% confidence intervals shown as interrupted lines) of end stage renal disease by urinary kappa/creatinine ratio (a) and urinary lambda/creatinine ratio (b), adjusted for the competing risk of death.

Percentiles are shown as vertical dotted lines. Abbreviations: P = percentile.

More »

Fig 4 Expand

Fig 5.

Cumulative incidence of end stage renal disease by quartiles of urinary kappa/creatinine ratio (a) and lambda/creatinine ratio (b).

Abbreviations: ESRD = end stage renal disease; KCR = kappa/creatinine ratio; LCR = lambda/creatinine ratio; Q = quartile.

More »

Fig 5 Expand

Table 3.

Subhazard ratios with 95% confidence intervals in univariable competing-risk models for risk of end stage renal disease accounting for the competing risk of death.

More »

Table 3 Expand

Table 4.

Subhazard ratios with 95% confidence intervals for urinary free light chain/creatinine ratios as continuous and categorical (above 75th centile) predictors in multivariable competing risk models for end-stage renal disease, adjusted for the competing risk of death.

More »

Table 4 Expand

Table 5.

Logistic regression models for the prediction of end stage renal disease at two years, with measures of model performance and the incremental value of adding kappa/creatinine ratio (KCR) or lambda/creatinine ratio (LCR) to a baseline model containing the kidney failure risk equation (KFRE).

More »

Table 5 Expand